Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility <i>in vitro</i>

Antiviral Therapy - Tập 15 Số 8 - Trang 1151-1159 - 2010
Larisa V. Gubareva1, A. Angelica Trujillo1, Margaret Okomo‐Adhiambo1, Vasiliy P. Mishin1, Varough Deyde1, Katrina Sleeman1, Ha Nguyen1, Tiffany G. Sheu1, Rebecca Garten1, Michael W. Shaw1, Alicia M. Fry1, Alexander Klimov1
1Virus Surveillance and Diagnosis Branch, Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA

Tóm tắt

Background Antiviral drugs are an important option for managing infections caused by influenza viruses. This study assessed the drug susceptibility of 2009 pandemic influenza A (H1N1) viruses collected globally between April 2009 and January 2010. Methods Virus isolates were tested for adamantane susceptibility, using pyrosequencing to detect the S31N marker of adamantane resistance in the M2 protein and biological assays to assess viral replication in cell culture. To assess neuraminidase (NA) inhibitor (NAI) susceptibility, virus isolates were tested in chemiluminescent NA inhibition assays and by pyrosequencing to detect the H275Y (H274Y in N2 numbering) marker of oseltamivir resistance in the NA. Results With the exception of three, all viruses that were tested for adamantane susceptibility ( n=3,362) were resistant to this class of drugs. All viruses tested for NAI susceptibility ( n=3,359) were sensitive to two US Food and Drug Administration-approved NAIs, oseltamivir (mean ±sd 50% inhibitory concentration [IC50] 0.25 ±0.12 nM) and zanamivir (mean IC50 0.29 ±0.09 nM), except 23 (0.7%), which were resistant to oseltamivir, but sensitive to zanamivir. Oseltamivir-resistant viruses had the H275Y mutation in their NA and were detected in patients exposed to the drug through prophylaxis or treatment. NA activity of all viruses was inhibited by the NAIs peramivir, laninamivir (R-125489) and A-315675, except for H275Y variants, which exhibited approximately 100-fold reduction in peramivir susceptibility. Conclusions This report provides data regarding antiviral susceptibility of 2009 pandemic influenza A (H1N1) surveillance viruses, the majority of which were resistant to adamantanes and sensitive to NAIs. These findings provide information essential for antiviral resistance monitoring and development of novel diagnostic tests for detecting influenza antiviral resistance.

Từ khóa


Tài liệu tham khảo

Centers for Disease Control and Prevention., 2009, MMWR Morb Mortal Wkly Rep, 58, 435

10.1056/NEJMoa0903810

10.1126/science.1176225

Centers for Disease Control and Prevention., 2009, MMWR Morb Mortal Wkly Rep, 58, 1100

10.1038/nature08182

Centers for Disease Control and Prevention., 2009, MMWR Morb Mortal Wkly Rep, 58, 433

10.1038/nature08260

10.1128/AAC.01417-09

10.1128/AAC.00555-08

10.1006/abio.2000.4517

10.1128/AAC.01339-05

10.1111/j.1750-2659.2009.00103.x

10.1073/pnas.0902548106

10.1016/j.jtbi.2009.03.003

10.1016/S0891-5520(20)30120-3

10.1056/NEJM198912213212502

10.3201/eid1504.181280

10.1016/0003-2697(79)90362-2

10.1038/nature05114

10.1038/nature05003

10.1128/AAC.47.7.2264-2272.2003

10.1586/erm.09.21

10.1002/(SICI)1099-1654(200001/02)10:1<45::AID-RMV265>3.0.CO;2-R

10.1093/jac/18.Supplement_B.19

10.1016/S0140-6736(05)67338-2

10.1086/518936

10.1099/vir.2008.007260-0

10.1159/000094244

10.1016/j.antiviral.2007.08.007

10.1086/504723

10.1001/jama.295.8.joc60020

10.1016/j.bmc.2005.12.056

10.1038/nrd2175

10.1146/annurev.med.59.061506.213121

Barroso L., 2005, Antivir Ther, 10, 901, 10.1177/135965350501000805

10.1016/j.antiviral.2005.10.002

10.1086/586711

10.1016/j.virol.2007.12.029

Centers for Disease Control and Prevention. Termination of the Emergency Use Authorization (EUA) of Medical Products and Devices. (Updated 24 June 2010. Accessed 23 September 2010.) Available from http://www.cdc.gov/h1n1flu/eua/peramivir.htm.

10.1358/dot.2010.46.6.1459659

10.1086/651605

10.1021/jm0002679

10.1128/AAC.46.12.3809-3816.2002

10.1128/AAC.00333-08

10.1128/AAC.00731-09

10.1128/AAC.48.12.4542-4549.2004

10.1021/jm040891b

10.1128/AAC.01755-09

10.1016/j.antiviral.2007.08.008

10.1086/500464

10.1128/AAC.49.11.4515-4520.2005

10.1128/JVI.01200-09

10.1016/j.antiviral.2009.11.005

Centers for Disease Control and Prevention. Flu review. 2009–2010 influenza season week 20 ending May 22, 2010. (Updated 28 May 2010. Accessed 23 September 2010.) Available from http://www.cdc.gov/flu/weekly.

Thông tin
Thông tin xuất bản

Antiviral Therapy

Tập 15 Số 8

1151-1159

Thông tin tác giả